HURA: tuhurabio.com Kompaniya qiymatining sof foydaga nisbati

TuHURA Biosciences - HURA emitenti grafik logotipi

TuHURA Biosciences, Inc. (HURA) biofarmatsevtika vaksinalarini ishlab chiqadi, bunda ulkan sinov xarajatlari patentlar tasdiqlanganidan keyin juda daromadli kengayish imkoniyatlari bilan almashtiriladi. Biznes samaradorligi biomateriallar uchun soddalashtirilgan, kechikishlarsiz ishlaydigan ekspress yetkazib berish tizimiga bog'liq. Ushbu grafik GURU.Markets platformasidagi joriy bozor qiymatini -3.00 darajasida aks ettiradi, garchi geosiyosiy beqarorlik va sanksiyalar xalqaro tadqiqotlarni sekinlashtirishi va xomashyo ta'minotini buzishi mumkin bo'lsa-da.

Narx-foyda koeffitsiyenti: TuHURA (HURA) 04.07.2022 - 16.11.2026 uchun

TuHURA Biosciences Inc. (HURA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning umumiy tahlili:TuHURA, HURA
TuHURA Biosciences yetakchi tovari

AIga asoslangan vaksinalar bo'yicha ixtisoslashgan TuHURA Biosciences, Inc. (HURA) uchun kompaniyaning prognoz qilingan P/E ko'rsatkichi yuqori ishlab chiqish xavflari fonida bozorning kelajakdagi daromadlar bo'yicha kutganlarini aks ettiradi. Ushbu ko'rsatkich joriy aksiya narxini oddiy aksiya uchun prognoz qilingan daromadlar bilan bog'laydi. Investorlar platformaning texnologik salohiyati uchun to'langan premium miqdorini aniqlash uchun investitsiyalarning qoplanish muddatini baholaydilar. Ushbu metrikaning monitoringi aktivlarning haddan tashqari qimmat baholanishi holatida yo'qotishlarni minimallashtirgan holda, portfelni o'z vaqtida qayta muvozanatlash imkonini beradi.

Raqobatdosh kompaniyalar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|TARA (Protara Therapeutics) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Fate Therapeutics Corp (FATE)|Narx-foyda koeffitsiyenti WHWK|Narx-foyda multiplikatori TCRX (TScan Therapeutics, Inc.)|P/E multiplikatori CSBR|XBIT - Kapitalizatsiyaning foydaga nisbati|CEL-SCI Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OSTX|radiopharmtheranostics.com - P/E multiplikatori|ARTV: Narxning foydaga nisbati|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV